美女免费一级视频在线观看

    1. <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      For Kathy Bloomgarden, CEO of Ruder Finn, the question “What’s next?” has been a consistent theme of her career. It practically defines her approach to leading one of the world’s largest independent communications and integrated marketing agencies. Over the past 25 years, Bloomgarden has positioned the agency at the forefront of the healthcare industry.

      This trajectory began as far back as 2001. In May of that year, Gleevec, a breakthrough drug that is 99% effective for chronic myeloid leukemia, appeared on the cover of Time with the headline “New Hope for Cancer.” Gleevec has saved an estimated 350,000 lives since its approval and Bloomgarden spread the word about its potential. It marked the beginning of her career-long commitment to championing breakthrough cures.

      At Ruder Finn, her work with major pharmaceutical companies including Pfizer, Novartis, Sanofi and Kite, as well as smaller startups, demonstrates an ability to help industry leaders embrace new technologies and strategies that address business needs while also driving positive societal impact. From accelerating COVID-19 vaccine development to advancing tests to diagnose Alzheimer’s, Bloomgarden has played a key role encouraging innovation in a variety of contexts.

      Click here to return to the 2025 MM+M Pinnacle Awards landing page.